Abatacept in spondyloarthritis refractory to tumour necrosis factor alpha inhibition.
Olivieri
I
I
D'Angelo
S
S
Mennillo
G A
GA
Pistone
G
G
Scarano
E
E
Padula
A
A
D000069594:Abatacept; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D025241:Spondylarthritis / Q000188:drug therapy* / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D018796:Immunoconjugates; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069594:Abatacept